Invention Grant
- Patent Title: Fused bicyclic imidazoles
- Patent Title (中): 稠合双环咪唑
-
Application No.: US12191706Application Date: 2008-08-14
-
Publication No.: US08592591B2Publication Date: 2013-11-26
- Inventor: Swen Hölder , Armin Zülch , Thomas Bär , Thomas Maier , Astrid Zimmermann , Thomas Beckers , Volker Gekeler , Hemant Joshi , Yogesh Munot , Umesh Bhise , Sunil Chavan , Sachin Shivatare , Sarvesh Patel , Vikas Gore
- Applicant: Swen Hölder , Armin Zülch , Thomas Bär , Thomas Maier , Astrid Zimmermann , Thomas Beckers , Volker Gekeler , Hemant Joshi , Yogesh Munot , Umesh Bhise , Sunil Chavan , Sachin Shivatare , Sarvesh Patel , Vikas Gore
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Priority: IN1573/MUM/2007 20070814; EP07118733 20071018
- Main IPC: C07D401/04
- IPC: C07D401/04 ; C07D401/14 ; A61K31/4188 ; A61K31/4465 ; A61P35/00
Abstract:
Compounds of formula (I) a tautomer or stereoisomer thereof, or a salt thereof, wherein ring B and the imidazole to which it is fused, R4, R6 and R7 have the meanings as given in the description and the claims, are effective inhibitors of the Pi3K/Akt pathway.
Public/Granted literature
- US20090156604A1 FUSED BICYCLIC IMIDAZOLES Public/Granted day:2009-06-18
Information query
